This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

NHS Somerset has launched a campaign to persuade older people in the county to have the free Respiratory Syncytial Virus (RSV) vaccination. Often starting as a simple cold, RSV can quickly lead to ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) ...

Adults hospitalized with RSV-associated ARI faced persistent long-term adverse outcomes when compared with those with influenza-associated ARI or no recent ARI.

Respiratory viruses are usually most active from October through March, health officials say.

CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The ...

Respiratory virus season is upon the United States as the cold weather months set in, meaning cases of COVID-19, influenza and RSV are set to increase. In its annual outlook report, the Centers for ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...

In 2024, the number of cases in North Carolina was ranked "high" by the CDC. How are we faring in 2025?

As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...